Target intelligence / Profile preview

Ocular surface tissue hydration

Molecular classification
Other (not a molecule, receptor, enzyme, transporter, or gene)
01

Overview

"Ocular surface tissue hydration" refers to the physiological state in which the tissues covering the front part of the eye—primarily the cornea and conjunctiva—are adequately moistened by tears. This is essential for maintaining optical clarity, protecting against environmental insults, supporting epithelial healing, and preventing frictional damage from blinking. The process depends on several factors including tear production by lacrimal glands, mucin secretion by goblet cells in the conjunctiva, lipid layer integrity from meibomian glands reducing evaporation, and active fluid transport across corneal endothelium via ion pumps. Disruption in any component can lead to dry eye disease or other forms of ocular discomfort and pathology such as filamentary keratitis. While many drugs aim to enhance or restore this function—such as artificial tears or anti-inflammatory agents—the term itself does not refer to a discrete molecular entity but rather an emergent property resulting from multiple biological systems working together[2][3]. There is no single molecule/receptor named "Ocular surface tissue hydration," so it should not be considered a canonical therapeutic target. If you are seeking information about specific molecules involved in regulating this process—such as aquaporins, sodium-potassium ATPase pumps on endothelial cells,[2] mucins,[3] etc.—please specify further. In summary: **"Ocular surface tissue hydration" is not a molecular target but describes an important physiological condition maintained by multiple cellular processes at the front of the eye.[1][2][3]**

Other names
Ocular surface hydrationCorneal hydrationTear film maintenance
02

Mechanism of action

Not applicable

03

Biological functions

Maintenance of ocular surface moistureProtection of corneal and conjunctival epitheliumPrevention of epithelial defects and friction-related injury[3]Regulation of corneal thickness and transparency[2]
04

Disease associations

Dry eye disease[3]Filamentary keratitis[3]Ocular surface disorders (general)[3]

Beyond the preview

Go deeper on Ocular surface tissue hydration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface tissue hydration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call